Gates Open Research publishes scholarly articles reporting any basic scientific, translational, applied and clinical research (including quantitative and qualitative studies) that has been funded (or co-funded) by the Bill & Melinda Gates Foundation.
Each publication must have at least one author who has been, or still is, a recipient of a Gates Foundation grant.
Articles must be original (not duplications). All research, including clinical trials, systematic reviews, software tools, method articles, and many others, is welcome and will be published irrespective of the perceived level of interest or novelty; confirmatory and negative results, as well as null studies are all suitable. See the full list of article types we accept for more information.
For papers submitted after August 2024, all articles are first published as preprints on our associated preprint server, VeriXiv, using a fully transparent model; the authors are solely responsible for the content of their article. Invited peer review takes place openly after publication on VeriXiv and once the article has reached the ‘passed peer review’ threshold the final version of record will be published on Gates Open Research, where it will benefit from all the indexing that Gates Open Research articles enjoy.
In addition to scholarly articles, Gates Open Research publishes other research outputs, collectively called documents, such as end-of-grant reports or guidelines, that vary in formats and often differ from traditional scholarly publications. It also publishes posters and slides. Documents, posters and slides are not peer reviewed and do not appear in bibliographic databases such as PubMed.
Gates Open Research is an Open Research platform: all content is published open access under a CC-BY license; the publishing and peer-review processes are fully transparent on VeriXiv; and authors of articles are asked to include detailed descriptions of methods and to provide full and easy access to the source data underlying the results in order to improve reproducibility.